361 related articles for article (PubMed ID: 16964294)
1. Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas.
Zucman-Rossi J; Benhamouche S; Godard C; Boyault S; Grimber G; Balabaud C; Cunha AS; Bioulac-Sage P; Perret C
Oncogene; 2007 Feb; 26(5):774-80. PubMed ID: 16964294
[TBL] [Abstract][Full Text] [Related]
2. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W
Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma.
Kim YD; Park CH; Kim HS; Choi SK; Rew JS; Kim DY; Koh YS; Jeung KW; Lee KH; Lee JS; Juhng SW; Lee JH
J Gastroenterol Hepatol; 2008 Jan; 23(1):110-8. PubMed ID: 18171349
[TBL] [Abstract][Full Text] [Related]
4. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas.
Ishizaki Y; Ikeda S; Fujimori M; Shimizu Y; Kurihara T; Itamoto T; Kikuchi A; Okajima M; Asahara T
Int J Oncol; 2004 May; 24(5):1077-83. PubMed ID: 15067328
[TBL] [Abstract][Full Text] [Related]
6. Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations.
Audard V; Grimber G; Elie C; Radenen B; Audebourg A; Letourneur F; Soubrane O; Vacher-Lavenu MC; Perret C; Cavard C; Terris B
J Pathol; 2007 Jul; 212(3):345-52. PubMed ID: 17487939
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of orphan G-protein-coupled receptor, Gpr49, in human hepatocellular carcinomas with beta-catenin mutations.
Yamamoto Y; Sakamoto M; Fujii G; Tsuiji H; Kenetaka K; Asaka M; Hirohashi S
Hepatology; 2003 Mar; 37(3):528-33. PubMed ID: 12601349
[TBL] [Abstract][Full Text] [Related]
8. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.
Qin X; Zhang H; Zhou X; Wang C; Zhang H; Zhang X; Ye L
Transl Res; 2007 Nov; 150(5):281-94. PubMed ID: 17964517
[TBL] [Abstract][Full Text] [Related]
9. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
[TBL] [Abstract][Full Text] [Related]
10. Beta-catenin and cyclin D1 expression in human hepatocellular carcinoma.
Ueta T; Ikeguchi M; Hirooka Y; Kaibara N; Terada T
Oncol Rep; 2002; 9(6):1197-203. PubMed ID: 12375019
[TBL] [Abstract][Full Text] [Related]
11. Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.
Renard CA; Labalette C; Armengol C; Cougot D; Wei Y; Cairo S; Pineau P; Neuveut C; de Reyniès A; Dejean A; Perret C; Buendia MA
Cancer Res; 2007 Feb; 67(3):901-10. PubMed ID: 17283120
[TBL] [Abstract][Full Text] [Related]
12. Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis.
Mao TL; Chu JS; Jeng YM; Lai PL; Hsu HC
J Pathol; 2001 Jan; 193(1):95-101. PubMed ID: 11169521
[TBL] [Abstract][Full Text] [Related]
13. Mutations of beta-catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis.
Park JY; Park WS; Nam SW; Kim SY; Lee SH; Yoo NJ; Lee JY; Park CK
Liver Int; 2005 Feb; 25(1):70-6. PubMed ID: 15698401
[TBL] [Abstract][Full Text] [Related]
14. Human homolog of NOTUM, overexpressed in hepatocellular carcinoma, is regulated transcriptionally by beta-catenin/TCF.
Torisu Y; Watanabe A; Nonaka A; Midorikawa Y; Makuuchi M; Shimamura T; Sugimura H; Niida A; Akiyama T; Iwanari H; Kodama T; Zeniya M; Aburatani H
Cancer Sci; 2008 Jun; 99(6):1139-46. PubMed ID: 18429952
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of regenerating islet-derived 1 alpha and 3 alpha genes in human primary liver tumors with beta-catenin mutations.
Cavard C; Terris B; Grimber G; Christa L; Audard V; Radenen-Bussiere B; Simon MT; Renard CA; Buendia MA; Perret C
Oncogene; 2006 Jan; 25(4):599-608. PubMed ID: 16314847
[TBL] [Abstract][Full Text] [Related]
16. Novel candidate targets of Wnt/beta-catenin signaling in hepatoma cells.
Lee HS; Park MH; Yang SJ; Park KC; Kim NS; Kim YS; Kim DI; Yoo HS; Choi EJ; Yeom YI
Life Sci; 2007 Jan; 80(7):690-8. PubMed ID: 17157329
[TBL] [Abstract][Full Text] [Related]
17. P53 mutation as a source of aberrant beta-catenin accumulation in cancer cells.
Cagatay T; Ozturk M
Oncogene; 2002 Nov; 21(52):7971-80. PubMed ID: 12439747
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma.
Merle P; Kim M; Herrmann M; Gupte A; Lefrançois L; Califano S; Trépo C; Tanaka S; Vitvitski L; de la Monte S; Wands JR
J Hepatol; 2005 Nov; 43(5):854-62. PubMed ID: 16098625
[TBL] [Abstract][Full Text] [Related]
19. Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver.
Kim Y; Sills RC; Houle CD
Toxicol Pathol; 2005; 33(1):175-80. PubMed ID: 15805069
[TBL] [Abstract][Full Text] [Related]
20. In vitro RNA interference against beta-catenin inhibits the proliferation of pediatric hepatic tumors.
Sangkhathat S; Kusafuka T; Miao J; Yoneda A; Nara K; Yamamoto S; Kaneda Y; Fukuzawa M
Int J Oncol; 2006 Mar; 28(3):715-22. PubMed ID: 16465377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
